Publications

Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines.

Keller-Stanislawski, B; Englund, JA; Kang, G; MANGTANI, P; Neuzil, K; Nohynek, H; Pless, R; Lambach, P; Zuber, P;

2014

Vaccine, (2014).32 52 10.1016/j.vaccine.2014.09.052.

Arrested Plasmodium liver stages as experimental anti-malaria vaccines.

Matuschewski, K; HAFALLA, JC; Borrmann, S; Friesen, J;

2014

Human vaccines, (2014).7 Supp sup1 10.4161/hv.7.0.14557.

Age-dependent prevalence of nasopharyngeal carriage of streptococcus pneumoniae before conjugate vaccine introduction: a prediction model based on a meta-analysis.

LE POLAIN DE WAROUX, O; FLASCHE, S; PRIETO-MERINO, D; EDMUNDS, WJ;

2014

PloS one, (2014).9 1 10.1371/journal.pone.0086136.

The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries.

BURCHETT, HE D; MOUNIER-JACK, S; TORRES-RUEDA, S; GRIFFITHS, UK; Ongolo-Zogo, P; Rulisa, S; Edengue, J-M; Chavez, E; Kitaw, Y; Molla, M; Konate, M; Gelmon, L; Onyango-Ouma, W; LAGARDE, M; MILLS, A;

2014

Vaccine, (2014).32 48 10.1016/j.vaccine.2014.09.031.

Seven challenges in modeling vaccine preventable diseases.

Metcalf, CJ E; Andreasen, V; Bjørnstad, ON; EAMES, K; EDMUNDS, WJ; FUNK, S; Hollingsworth, TD; Lessler, J; Viboud, C; Grenfell, BT;

2014

Epidemics, (2014).10, 10.1016/j.epidem.2014.08.004.

Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial.

Hammitt, LL; OJAL, J; Bashraheil, M; Morpeth, SC; Karani, A; Habib, A; Borys, D; Goldblatt, D; SCOTT, JA G;

2014

PloS one, (2014).9 1 10.1371/journal.pone.0085459.

Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.

CUCCUI, J; WREN, B;

2014

The Journal of pharmacy and pharmacology, (2014).67 3 10.1111/jphp.12321.

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.

RTS,S Clinical Trials Partnership,;

2014

PLoS medicine, (2014).11 7 10.1371/journal.pmed.1001685.

Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system.

MOUNIER-JACK, S; BURCHETT, HE D; GRIFFITHS, UK; Konate, M; Diarra, KS;

2014

Global health, science and practice, (2014).2 1 10.9745/GHSP-D-13-00130.

The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review.

Roy, A; Eisenhut, M; Harris, R; Rodrigues, L; Sridhar, S; Habermann, S; Snell, L; MANGTANI, P; Adetifa, I; Lalvani, A; Abubakar, I;

2014

EUROPEAN RESPIRATORY JOURNAL, (2014).44,